IGSF3 tissue expression in squamous cell carcinoma of the oropharynx: a novel tool for prognosis assessment in HPV-related and HPV-unrelated disease.
HPV
OPSCC
biomarker
immunohistochemistry
prognosis
Journal
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ISSN: 1600-0463
Titre abrégé: APMIS
Pays: Denmark
ID NLM: 8803400
Informations de publication
Date de publication:
16 Apr 2024
16 Apr 2024
Historique:
received:
29
08
2023
accepted:
02
04
2024
medline:
16
4
2024
pubmed:
16
4
2024
entrez:
16
4
2024
Statut:
aheadofprint
Résumé
Biomarkers are not broadly used in the management of head and neck cancers (HNCs). Biomarkers have been beneficial in the management of other cancers, however, not in HNCs. Therefore, we observed the immunopositivity of a novel biomarker called immunoglobulin superfamily member 3 (IGSF3) in tumor tissues in HPV-related and HPV-unrelated OPSCC. Two patient cohorts (C1 and C2) from separate time periods were available for this study (total N = 282). Both consisted of OPSCC patients treated at the Helsinki University Hospital (HUS, Helsinki, Finland) during 2000-2016. For HPV determination, HPV mRNA in situ hybridization was used. Immunohistochemistry was used to assess IGSF3 immunopositivity in cancer tissues. Overall survival (OS) was used as endpoint in the statistical analysis. In C1, stronger immunopositivity of IGSF3 in tumor-infiltrating lymphocytes (TILs) correlated with favorable OS (p = 0.005). Stronger IGSF3 immunopositivity in tumor cells (TCs) was associated with HPV negativity (p = 0.017). Stronger IGSF3 immunopositivity in TILs correlated with HPV positivity (p < 0.001). Elevated IGSF3 immunopositivity in TILs associates with HPV-related tumors and may signify favorable prognosis. The immunopositivity of IGSF3 differs between HPV-related and HPV-unrelated OPSCC.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
ID : 220089
Pays : United Kingdom
Informations de copyright
© 2024 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Pathology, Medical Microbiology and Immunology.
Références
Parvathaneni U, Lavertu P, Gibson MK, Glastonbury CM. Advances in diagnosis and multidisciplinary Management of Oropharyngeal Squamous Cell Carcinoma: state of the art. Radiographics. 2019;39(7):2055–2068.
Jager‐Wittenaar H, Dijkstra PU, Vissink A, van der Laan BF, van Oort RP, Roodenburg JL. Malnutrition and quality of life in patients treated for oral or oropharyngeal cancer. Head Neck. 2011;33(4):490–496.
García‐Peris P, Parón L, Velasco C, de la Cuerda C, Camblor M, Bretón I, et al. Long‐term prevalence of oropharyngeal dysphagia in head and neck cancer patients: impact on quality of life. Clin Nutr. 2007;26(6):710–717.
Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma‐‐an update. CA Cancer J Clin. 2015;65(5):401–421.
Huang Y, Lan Y, Zhang Z, Xiao X, Huang T. An update on the immunotherapy for oropharyngeal squamous cell carcinoma. Front Oncol. 2022;12:800315.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
Ansinelli H, Gay C, Nguyen S, Morrison CM, Robbins JR. Personalized precision radiotherapy and its evolving role for human papillomavirus‐positive oropharyngeal cancer. J Natl Cancer Center. 2023;3(1):72–82.
Valdes G, Simone CB 2nd, Chen J, Lin A, Yom SS, Pattison AJ, et al. Clinical decision support of radiotherapy treatment planning: a data‐driven machine learning strategy for patient‐specific dosimetric decision making. Radiother Oncol. 2017;125(3):392–397.
Duffy MJ, Crown J. A personalized approach to cancer treatment: how biomarkers can help. Clin Chem. 2008;54(11):1770–1779.
Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, Hayes DF, et al. NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. J Natl Compr Canc Netw. 2011;9 Suppl 5:S1–S32. quiz S3.
Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.
Suzuki H, Kawasaki Y, Miura M, Hatakeyama H, Shina K, Suzuki S, et al. Tumor infiltrating lymphocytes are prognostic factors and can Be markers of sensitivity to chemoradiotherapy in head and neck squamous cell carcinoma. Asian Pac J Cancer Prev. 2022;23(4):1271–1278.
Halaby DM, Mornon JP. The immunoglobulin superfamily: an insight on its tissular, species, and functional diversity. J Mol Evol. 1998;46(4):389–400.
Usardi A, Iyer K, Sigoillot SM, Dusonchet A, Selimi F. The immunoglobulin‐like superfamily member IGSF3 is a developmentally regulated protein that controls neuronal morphogenesis. Dev Neurobiol. 2017;77(1):75–92.
Saupe S, Roizès G, Peter M, Boyle S, Gardiner K, De Sario A. Molecular cloning of a human cDNA IGSF3 encoding an immunoglobulin‐like membrane protein: expression and mapping to chromosome band 1p13. Genomics. 1998;52(3):305–311.
Curry RN, Aiba I, Meyer J, Lozzi B, Ko Y, McDonald MF, et al. Glioma epileptiform activity and progression are driven by IGSF3‐mediated potassium dysregulation. Neuron. 2023;111(5):682–695.
Sheng P, Zhu H, Zhang W, Xu Y, Peng W, Sun J, et al. The immunoglobulin superfamily member 3 (IGSF3) promotes hepatocellular carcinoma progression through activation of the NF‐κB pathway. Ann Transl Med. 2020;8(6):378.
Shao S, Piao L, Guo L, Wang J, Wang L, Wang J, et al. Tetraspanin 7 promotes osteosarcoma cell invasion and metastasis by inducing EMT and activating the FAK‐Src‐Ras‐ERK1/2 signaling pathway. Cancer Cell Int. 2022;22(1):183.
Jouhi L, Mohamed H, Mäkitie A, Remes SM, Haglund C, Atula T, et al. Toll‐like receptor 5 and 7 expression may impact prognosis of HPV‐positive oropharyngeal squamous cell carcinoma patients. Cancer Immunol Immunother. 2017;66(12):1619–1629.
Sjöblom A, Carpén T, Stenman UH, Jouhi L, Haglund C, Syrjänen S, et al. The role of human chorionic gonadotropin Beta (hCGβ) in HPV‐positive and HPV‐negative oropharyngeal squamous cell carcinoma. Cancers (Basel). 2022;14(12):2830.
Carpén T, Sjöblom A, Lundberg M, Haglund C, Markkola A, Syrjänen S, et al. Presenting symptoms and clinical findings in HPV‐positive and HPV‐negative oropharyngeal cancer patients. Acta Otolaryngol. 2018;138(5):513–518.
Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant Tumours. 7th ed. Wiley‐Blackwell: Hoboken, NJ, USA; 2009.
Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant Tumours. 8th ed. Wiley‐Blackwell: Hoboken, NJ, USA; 2016.
Randén‐Brady R, Carpén T, Jouhi L, Syrjänen S, Haglund C, Tarkkanen J, et al. In situ hybridization for high‐risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer. Hum Pathol. 2019;90:97–105.
Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, et al. Detection of transcriptionally active high‐risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36(12):1874–1882.
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen‐Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.
Watanabe T, Miura T, Degawa Y, Fujita Y, Inoue M, Kawaguchi M, et al. Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real‐time PCR. Cancer Cell Int. 2010;10:2.
Xiao J, Sharma U, Arab A, Miglani S, Bhalla S, Suguru S, et al. Propagated circulating tumor cells uncover the potential role of NFκB, EMT, and TGFβ signaling pathways and COP1 in metastasis. Cancers (Basel). 2023;15(6):1831.
Zhang HH, Zhang ZY, Che CL, Mei YF, Shi YZ. Array analysis for potential biomarker of gemcitabine identification in non‐small cell lung cancer cell lines. Int J Clin Exp Pathol. 2013;6(9):1734–1746.
Xie L, Yao Z, Zhang Y, Li D, Hu F, Liao Y, et al. Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis. Cell Death Dis. 2018;9(7):772.
Li X, Wang Y, Xu C, Reheman X, Wang Y, Xu R, et al. Analysis of competitive endogenous mechanism and survival prognosis of serum exosomes in ovarian cancer patients based on sequencing technology and bioinformatics. Front Genet. 2022;13:850089.
Huang KC, Chiang SF, Ke TW, Chen WT, Chen TW, Chao KC. The clinical relevance of frequent germline genetic variants detected by targeted sequencing in patients with rectal adenocarcinoma (READ). Cancer Genomics Proteomics. 2020;17(3):291–299.
Soikkeli J, Podlasz P, Yin M, Nummela P, Jahkola T, Virolainen S, et al. Metastatic outgrowth encompasses COL‐I, FN1, and POSTN up‐regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth. Am J Pathol. 2010;177(1):387–403.
Lazo PA. Functional implications of tetraspanin proteins in cancer biology. Cancer Sci. 2007;98(11):1666–1677.
Rivas A, Ruegg CL, Zeitung J, Laus R, Warnke R, Benike C, et al. V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies. J Immunol. 1995;154(9):4423–4433.